Computational studies on potential new anti-Covid-19 agents with a multi-target mode of action

A compound that could inhibit multiple targets associated with SARS-CoV-2 infection would prove to be a drug of choice against the virus. Human receptor-ACE2, receptor binding domain (RBD) of SARS-CoV-2 S-protein, Papain-like protein of SARS-CoV-2 (PLpro), reverse transcriptase of SARS-CoV-2 (RdRp)...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohapatra, Ranjan K., Azam, Mohammad, Mohapatra, Pranab K., Sarangi, Ashish K., Abdalla, Mohnad, Perekhoda, Lina, Yadav, Oval, Al-Resayes, Saud I., Jong-Doo, Kim, Dhama, Kuldeep, Ansari, Azaj, Seidel, Veronique, Verma, Sarika, Raval, Mukesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. on behalf of King Saud University. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101701/
https://www.ncbi.nlm.nih.gov/pubmed/35582633
http://dx.doi.org/10.1016/j.jksus.2022.102086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101701/
https://www.ncbi.nlm.nih.gov/pubmed/35582633
http://dx.doi.org/10.1016/j.jksus.2022.102086

Ejemplares similares